awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26801911-2E2CA89D-3780-404C-801A-1020D524C92E
Q26801911-2E2CA89D-3780-404C-801A-1020D524C92E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26801911-2E2CA89D-3780-404C-801A-1020D524C92E
Anti-angiogenic agents in metastatic colorectal cancer
P2860
Q26801911-2E2CA89D-3780-404C-801A-1020D524C92E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26801911-2E2CA89D-3780-404C-801A-1020D524C92E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
99f4be963f675da9a7234ffef8d2f3d409332718
P2860
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.